Care Pathway for Patients With Fabry's Disease (Fabry-PATH)
NCT07485660 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 200
Last updated 2026-03-20
Summary
Fabry's disease is an X-linked disorder that manifests differently in men and women, leading to differences in healthcare pathways. In women, the disease is sometimes diagnosed through family screening despite the presence of symptoms (symptoms appear later than in men, and the phenotypic expression of the disease is sometimes more subtle). Conversely, in men, the presence of symptoms combined with abnormalities in medical examinations facilitates diagnosis. There is limited data on the differences in healthcare pathways between men and women, which could nevertheless impact diagnosis by identifying a profile of at-risk patients, and consequently, their management.
The goal of this present study is to describe the differences in care pathways between men and women with Fabry's disease, distinguishing entry via symptoms or family screening through a non-interventional study based on a questionnaire sent to patients and on the collection of medical data at the time of diagnosis.
Conditions
Interventions
- OTHER
-
Self-questionnaire
Medical data of Fabry's disease
Sponsors & Collaborators
-
University Hospital, Toulouse
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-04-30
- Primary Completion
- 2026-11-30
- Completion
- 2026-11-30
Countries
- France
Study Locations
More Related Trials
-
Evaluation of Phenotypic Variability in Fabry Disease
NCT03145779 ·Status: WITHDRAWN
-
Fabry Disease Registry & Pregnancy Sub-registry
NCT00196742 ·Status: RECRUITING
-
Fabry's Disease and Pregnancy (PREFAB)
NCT02582294 ·Status: TERMINATED
-
Prevalence of Fabry's Disease in a Population of Patients With Chronic Pains
NCT01178164 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Efficacy and Safety of Agalsidase Beta in Heterozygous Females for Fabry Disease
NCT00487630 ·Status: UNKNOWN ·Phase: PHASE4
-
Detection of Fabry Disease in Chronic Renal Failure Patients in Area Provence - Alpes - Côte d'Azur
NCT01374997 ·Status: COMPLETED ·Phase: NA
-
Study of the Prevalence of Fabry Disease in French Dialysis Patients
NCT02843334 ·Status: UNKNOWN
-
Biomarkers and Cardiac Imaging Diagnostic Assay for Monitoring Patients With Fabry Disease
NCT05698901 ·Status: RECRUITING
-
Data Collection in Women With Fabry Disease
NCT00030134 ·Status: COMPLETED
-
Prevalence and Characteristics of Fabry Disease (FD) in Patients With Stroke or Small Fiber Neuropathy
NCT03230149 ·Status: COMPLETED
-
Study to Evaluate the Safety, PK, PD, and Efficacy of PRX-102 in Japanese Patients With Fabry Disease
NCT05710692 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Studying Lipids as Potential Biomarkers in Patients With Fabry Disease
NCT05046379 ·Status: COMPLETED
-
An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression
NCT06079567 ·Status: RECRUITING ·Phase: NA
-
Stroke in Young Fabry Patients (sifap1): Frequency of Fabry Disease in Young Stroke Patients
NCT00414583 ·Status: COMPLETED
-
Understanding Fabry Disease Therapy Choices Through the Eyes of the Patients
NCT04804566 ·Status: COMPLETED
-
Open Label Extension Study of 1 mg/kg Pegunigalsidase Alfa Every 2 Weeks in Patients With Fabry Disease
NCT03566017 ·Status: COMPLETED ·Phase: PHASE3
-
Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive Testing
NCT05699265 ·Status: TERMINATED
-
Sophisticated Assessment of Disease Burden in Patients With Fabry Disease
NCT01210196 ·Status: COMPLETED
-
Long-term, Safety, Tolerability and Efficacy Study of AFQ056 in Adult Patients With Fragile X Syndrome
NCT01348087 ·Status: TERMINATED ·Phase: PHASE2
-
Registry of Fabry Disease - A Multicenter Observational Study
NCT00055016 ·Status: COMPLETED
-
Fabry Disease in Cerebrovascular Disease
NCT02859363 ·Status: UNKNOWN
-
A Study to Learn About the Safety and Effects of the Study Drug PRX-102 in Children and Adolescents With Fabry Disease
NCT06328608 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Epidemiological Study of Fabry Disease Screening in Chronic Kidney Disease Patients
NCT05056636 ·Status: UNKNOWN
-
Disease Progression in Women With X-linked Adrenoleukodystrophy
NCT06178120 ·Status: RECRUITING
-
Fabry and Cardiomyopathy (FaCard)
NCT01429597 ·Status: WITHDRAWN